30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Jack Glenn

Insider profile

Currently holds a position at Ekso Bionics Holdings Inc

Performance

Overall performance
2.4

Performance over holding periods
2.4
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 1% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Chief Financial Officer, Secretary Ekso Bionics Holdings Inc Aug. 13, 2018 -
Chief Financial Officer Sonendo Inc None -

Jack Glenn's trades of IRadimed Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-12-12 2025-12-11 S Sale
76,510 +48.1%
324.41
US$1,748,820
76,510 +48.1% 324.41 US$1,748,820
2025-12-12 2025-12-11 S Sale
52,759 +13.4%
222.74
US$2,259,763
52,759 +13.4% 222.74 US$2,259,763
2025-12-11 2025-12-11 PrS Proposed sale
49,501
120.25
US$881,598
49,501 120.25 US$881,598
2025-11-12 2025-11-10 S Sale
10,651 -81.0%
84.51
US$900,162
10,651 -81.0% 84.51 US$900,162
2025-11-10 2025-11-10 PrS Proposed sale
10,651
84.51
US$900,157
10,651 84.51 US$900,157
2025-01-06 2024-12-02 PrS Proposed sale
2,500
54.18
US$135,445
2,500 54.18 US$135,445
2024-12-02 2024-12-02 S Sale
2,500 -36.3%
54.18
US$135,449
2,500 -36.3% 54.18 US$135,449
2022-03-28 2022-03-22 S Sale
3,462 -9.0%
2.82
US$9,762
3,462 -9.0% 2.82 US$9,762
2019-06-19 2019-05-31 S Sale
10,292 -68.6%
1.37
US$14,100
10,292 -68.6% 1.37 US$14,100